Böttcher and colleagues (34) analyzed The Cancer Genome Atlas data and found that a cDC1 signature was positively correlated with an XCL1/XCL2 and CCL5 chemokine signature and an NK-cell signature in breast cancer, melanoma, and lung adenocarcinoma. Here, XCL2 is linked to lung adenocarcinoma.